title: Immunology. Considering therapeutic antibodies.
authors.affiliation: Cancer Immunobiology Center, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75235-8576, USA. ellen.vitetta@utsouthwestern.edu
authors.forename: Ellen S
authors.initials: ES
authors.lastname: Vitetta
authors.forename: Victor F
authors.initials: VF
authors.lastname: Ghetie
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000915:Antibody Affinity; D001666:Binding Sites, Antibody; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016207:Cytokines / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D006207:Half-Life; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000276:immunology; D007074:Immunoglobulin G / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D007167:Immunotherapy; D008213:Lymphocyte Activation; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D015202:Protein Engineering; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; C509303:TGN-1412